Fundraising Fox

Domain Partners

Venture capital

Princeton

Fox Verdict
Sign up to see your fit

Fund manager profile

Domain Partners is a venture fund manager based in Princeton. SEC filings show 1 venture fund on record, most recently Domain Partners IX, L.P. filed December 2016.

Source: SEC EDGAR Form D filings. Firm website data not yet available.

HQ
Princeton, US
Founded
2014
Tracked investments
6

What they invest in

from 5 of 6 portfolio companies

Biotech ×4Healthtech ×4Medical Devices ×2AI & Machine Learning ×1

HQs:United States×6

Investments · 6 tracked

founders shown can be your intro path

By year:2017 · 22016 · 32015 · 16 dated

aTYR PHARMAatyrpharma.com𝕏NASDAQ: ATYRMar 2015SEC filingmedium confidence

aTyr is a clinical-stage biotechnology company developing therapies derived from tRNA synthetase biology to treat fibrosis and inflammation, with its lead candidate efzofitimod in clinical trials for interstitial lung disease.

BiotechHealthtechMedical DevicesSan Diego, US

Paul Schimmel(Non-Management Director)John D. Mendlein(Executive Officer, Director)David Weiner(Executive Officer)Frederic Chereau(Executive Officer)

BoardAmir Nashat(Non-Management Director)inAkkaraju Srinivas(Non-Management Director)

Board seatJames C. Blair· per SEC Form D · $76.3M raise · filed Apr 2015

Co-investorsCardinal PartnersEcoR1 CapitalSofinnova VenturesPolaris PartnersSamsara BioCapital

Axial BiotherapeuticsNov 2016SEC filingmedium confidence

BiotechBoston, US

SARKIS K. MAZMANIAN(Director)DAVID H. DONABEDIAN(CHIEF EXECUTIVE OFFICER OF THE ISSUER)Ronald C. Renaud Jr.(Director)Henry Wolf(Director)

BoardMICHELLE DIPP(Director)

Board seatJames C. Blair· per SEC Form D · $19.1M raise · filed Jun 2017

Co-investorsLongwood Fund

ChromaCodechromacode.comin𝕏Apr 2017SEC filingmedium confidence

ChromaCode develops a High-Definition PCR (HDPCR) multiplexing platform that enables genomic solutions for oncology and precision medicine, offering faster results and cost-effective workflows through automated interpretation and cloud-based software.

AI & Machine LearningBiotechHealthtechMedical DevicesCarlsbad, US

Paul Flook(Executive Officer, Director)Gregory J. Gosch(Executive Officer, Director)Lynne Rollins(Executive Officer)Aditya Rajagopal(Director)Axel Scherer(Director)

BoardJustin Klein(Director)in

Board seatJames C. Blair· per SEC Form D · $12.1M raise · filed Apr 2017

Co-investorsAdjuvant CapitalGlobal BrainMoore Venture PartnersNew Enterprise Associates (NEA)Windham Capital PartnersDomain Associates+2 more

Miramar LabsJun 2016SEC filingmedium confidence

HealthtechSanta Clara, US

R. Michael Kleine(Executive Officer, Director)Brigid Makes(Executive Officer)Steven Kim(Executive Officer)Henry A. Plain, Jr.(Director)

BoardHanson Gifford III(Director)Henry Plain, Jr.(Director)

Board seatBrian H. Dovey· per SEC Form D · $33.6M raise · filed Jun 2016

Co-investorsLightstone Ventures

Orexigen Therapeuticscurraxpharma.cominFeb 2017SEC filingmedium confidence

Currax Pharmaceuticals develops and markets a portfolio of therapies for chronic progressive diseases.

BiotechHealthtechLa Jolla, US

Preston Klassen(Executive Officer)Joseph Hagan(Executive Officer)Michael Narachi(Executive Officer, Director)Thomas Cannell(Executive Officer)

BoardEckard Weber(Director)

Board seatBrian H. Dovey· per SEC Form D · $49.6M raise · filed Mar 2017

Co-investorsCross Creek AdvisorsNew Enterprise Associates (NEA)Sofinnova VenturesDomain Associates

Revision OpticsOct 2016SEC filingmedium confidence

Lake Forest, US

John T. Kilcoyne(Executive Officer, Director)Louis Bunn(Executive Officer)

BoardRenee Ryan(Director)Gilbert H. Kliman(Director)Wende Hutton(Director)inInna Martin Eitan(Director)

Board seatBrian H. Dovey· per SEC Form D · $45M raise · filed Nov 2016

Co-investorsCanaan Partners

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.

Exits · 1

IPOs and acquisitions across the tracked portfolio

aTYR PHARMANASDAQ: ATYR

Fund performance · per public LP disclosures · 2

as of Jun 2020
FundVintageCommittedNet IRRTVPIDPI
Domain Partners VII, L.P.LPs: The Regents of the University of California2006-1.4%0.95x0.95x
Domain Partners VI, L.P.LPs: The Regents of the University of California2003-4.8%0.81x0.81x

Source: public limited-partner disclosures (CalPERS, CalSTRS). Net IRR / TVPI / DPI as reported by the limited partner; a fund's early-year IRR is an interim estimate (J-curve).

Frequently asked questions

Where is Domain Partners located?
Domain Partners is headquartered in Princeton, US.

Featured in lists